LUNG TRANSPLANT RECIPIENT
Clinical trials for LUNG TRANSPLANT RECIPIENT explained in plain language.
Never miss a new study
Get alerted when new LUNG TRANSPLANT RECIPIENT trials appear
Sign up with your email to follow new studies for LUNG TRANSPLANT RECIPIENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Hepatitis b donor lungs: a new hope for transplant patients?
Disease control Recruiting nowThis study tests whether lungs from donors with hepatitis B can be safely transplanted into people who do not have the virus. The lungs are treated with UV light and antiviral drugs to kill the virus before transplant. Twenty recipients will be monitored for 6 months to see if th…
Matched conditions: LUNG TRANSPLANT RECIPIENT
Phase: PHASE4 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated May 17, 2026 00:32 UTC
-
New drug combo aims to knock out CMV faster in lung transplant patients
Disease control Recruiting nowThis study tests whether adding a drug called letermovir to the usual antiviral treatment helps clear CMV infection faster in people who have received a lung transplant. About 40 participants with active CMV will receive either letermovir or a placebo alongside standard care. The…
Matched conditions: LUNG TRANSPLANT RECIPIENT
Phase: PHASE4 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated May 14, 2026 12:02 UTC